Cutaneous manifestations of systemic sclerosis;Manifestações cutâneas na esclerose sistêmica

Acta Reumatologica Portuguesa

Volumn 35, Issue 2, 2010, Pages 184-190

  Bertazzi, Glauce Rejane Leonardi ^a   de Toledo, Roberto Acayaba ^a   de Godoy, Moacir Fernandes ^a   Geraldino, Geise Cristina ^a   Fernandes, Gisele Cristine Dyonisio ^a   Polizelli, Daniela Vichiato ^a   Pedroso, Camila Lobo ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Skin manifestation; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; SKIN DISEASE; SYSTEMIC SCLEROSIS;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN DISEASES; YOUNG ADULT;

EID: 78751665862     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Varga J. Systemic Sclerosis: Epidemiology, Pathology and Pathogenesis. In: Klippel JH, Stone JH, Crofford LJ, and White PH, Editors. Primer on the Rheumatic Diseases. Thirteenth Edition. New York: Springer, 2008:351-358.
2. Scussel-Lonzetti L, Joyal F, Raynauld J-P et al. Predicting mortality in systemic sclerosis analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81:154-167.
3. Hummers LK, Wigley FM. Escleroderma. In: Imboden, J; Hellmann D, Stone J, Editors. Current Rheumatology Diagnosis & Treatment. Second Edition. Lange Medical Books/McGraw-Hill, 2007:228-236.
4. Czirják L, Foeldvari I, Müller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology 2008; 47:44-45.
5. Leroy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
6. Mayes MD. Systemic Sclerosis: Clinical Features In: Klippel JH, Stone JH, Crofford LJ, and White PH, Editors. Primer on the Rheumatic Diseases. Thirteenth Edition. New York: Springer, 2008:334-362.
7. Guidolin F, Esmanhotto L, Magro CE, Silva MB, Skare TL. Prevalência de achados cutâneos em portadores de esclerose sistêmica Experiência de um hospital universitário. An Bras Dermatol 2005;80:481-486.
8. Hettema ME, Zhang D, Stienstra Y, Smit AJ, Bootsma H, Kallenberg CGM. No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis. Clin Rheumatol 2009;28:825-833.
9. Ashida R, Ihn H, Mimura Y, Jinnin M, Asano Y, Kubo M, Tamaki K. Clinical and laboratory features of Japonese patients with scleroderma and telangiectasia. Clin and Exp Dermatol 2009;34:781-783.
10. Korn JH, Mayes M, Matucci Cerinic M et al, to the study group RAPIDS-1. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50: 3985-3993.
11. Masi, AT. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590.
12. Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR. Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 2003;21:S5-S8.
13. Black C. Measurement of skin involvement in scleroderma. J Rheumatol 1995;22:1217-1219.
14. Clements PJ, Lachenbruch P, Seibold JR et al. Inter-and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-1285.
15. Mayes MD, Lacey JV, Beebe-Dimmer J et al. Prevalence, Incidence, Survival, and Disease Characteristics of Systemic Sclerosis in a Large Population. Arthritis Rheum 2003;48:2246-2255.
16. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004;43:1129-1137.
17. Czirják L, Kumánovics G, Varjú C et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
18. Ferri C, Valentini G, Cozzi F et al. Systemic Sclerosis Study Group of the Italian Society of Rheumathology (SIR-GSSSc). Systemic Sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine 2002;81:139-153.
19. Steen VD and Medsger TAJr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-2444.
20. Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, Rojas-Villarraga A, Anaya J-M. Systemic sclerosis: A world wide global analysis. Clin Rheumatol 2009;28:757-765.
21. Arias-Nuñes MC, LIorca J, Vazquez-Rodriguez TR et al. Systemic sclerosis in Northwestern Spain. A 19-year epidemiologic study. Medicine 2008;87:272-280.
22. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-686.
23. Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001;44:2828-2835.
24. Hanitsch LG, Burmester G-R, Witt C et al. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations-an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology 2009;48:70-73.
25. Sampaio-Barros PD, Samara AM, Marques Neto JF. Estudo sobre as diferentes formas clínicas e escores cutâneos na esclerose sistêmica. Rev Bras Reumatol 2004;44:1-8.
26. Sanchez JL, Vasquez M, Sanchez NP. Vitiligo like macules in systemic scleroderma. Arch Dermatol 1983;119:129-133.
27. Ee HL, Tan SH. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol 2005;30:131-133.
28. Krishna Sumanth M, Sharma VK, Khaitan BK et al. Evaluation of oral methotrexate in the treatment of systemic sclerosis. Int J Dermatol 2007;46: 218-223.
29. Shah AA, Wigley FM, Hummers LK. Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension. J Rheumatol 2010;37:98-104.
30. Thonhofer R, Siegel C. Extensive calcinosis cutis in limited cutaneous scleroderma. J Rheumatol 2009;36:2834-2835.
31. Steen VD. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg 1998;17:48-54.
32. Wigley F, Flavahan N. Raynaud's phenomenon. Rheum Dis Clin North Am 1996;22:765-781.
33. Alivernini S, De Santis M, Tolusso B et al. Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol 2009;60:426-435.
34. Sunderkötter C, Herrgott I, Brückner C et al. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol 2009;160:835-843.